-
EXCLUSIVE: Fireside With Enveric Biosciences's Dr. Tucker, Unlocking Psychedelic Healing Benefits
Thursday, April 20, 2023 - 5:02pm | 537Read More...Recently, at the Benzinga Psychedelic Capital Conference, leading experts from the biotech and pharmaceutical industry gathered to discuss the remarkable potential of psychedelics in medicine. Among the attendees was Enveric Biosciences Inc (NASDAQ: ENVB) CEO Dr. Joseph Tucker, who shared some...
-
ATAI Life Sciences Present A "New Recipe For Success" At The Psychedelic Capital Conference
Friday, April 29, 2022 - 8:55am | 172Read More...This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Glenn Short, PhD, Vice President of Early Development, at ATAI Life Sciences (NASDAQ: ATAI) was a guest speaker at Benzinga’s Psychedelic Capital...
-
Meet The Company Developing Innovative Peyote-Based Treatments For Addiction, Anxiety, And Depression
Friday, April 29, 2022 - 8:51am | 159Read More...This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Claire Stawnyczy, CEO of Lophos Pharmaceuticals Corp. was a guest speaker at Benzinga’s Psychedelics Capital Conference on April 19, 2022. Lophos...
-
Cybin Presents "Why Cybin Is Investing So Heavily On Developing Novel Psychedelic Molecules" At The Psychedelic Capital Conference
Monday, April 25, 2022 - 12:16pm | 192Read More...Photo by Presetbase Lightroom Presets on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Doug Drysdale, CEO, Cybin Inc. (NYSE: CYBN) was a guest speaker at Benzinga’s Psychedelic Capital...
